A less invasive alternative to surgery in the carotid artery.

There have been also some notable variations. For patients 69 years and more youthful, stenting results were superior to surgical results; the younger the patient, the larger the stenting advantage. Conversely, for patients over the age of 70, surgical results were better than stenting slightly; the older the patient, the bigger the surgery benefit.3 % compared to 1.1 % in the stenting group. The incidence of overall stroke was 4.1 % in the stent group vs. 2.3 % in the surgical group. Importantly, however, there is no difference for main, disabling strokes between the two groups.D., FSCAI, chairman, section of cardiology, and director of the Ochsner Heart & Vascular Institute, Ochsner INFIRMARY in New Orleans, and secretary of the Society for Cardiovascular Angiography and Interventions.This decrease is primarily because of completing our lorcaserin pivotal Stage 3 clinical trials. Research and development expenses included $2.6 million in non-cash, share-based compensation expense in the first nine months of 2010, compared to $2.9 million in the first nine months of 2009. General and administrative expenditures totaled $6.9 million in the 3rd quarter of 2010, compared to $5.4 million in the 3rd quarter of 2009, and $20.6 million in the first nine months of 2010, in comparison to $18.7 million in the first nine months of 2009. This increase is attributable to increased legal and marketing research expenses primarily. General and administrative expenditures in the initial nine months of 2010 included $1.7 million in non-cash, share-based compensation expense, compared to $2.2 million in the first nine months of 2009.

Other Posts From "pharmacy":

Related Posts